Thomson Reuters And GenomeQuest Deliver Combined Biological Sequence Patent Database Via The Web
Philadelphia, PA, London, UK — September 28, 2009 — Thomson Reuters and GenomeQuest, Inc. today announced a new partnership to integrate Thomson Reuters patent sequence data in GENESEQ with the GenomeQuest IP discovery tools. The product combination, available in September, provides intellectual property professionals and scientists with online, interactive access to an up-to-date, comprehensive source of biological sequence information.
GENESEQTM is a database from Thomson Reuters containing more than 29 million patented biological sequences, from over 150,000 unique patents across the global patent issuing authorities. Now, in addition to text file FTP access, GENESEQ can be accessed alongside GenomeQuest GQ-Pat, a complementary source of patented sequences, to offer an extensive repository for patent sequence information. This information, delivered through GenomeQuest’s secure internet subscription service, offers users the potential to quickly and accurately discover comprehensive biological sequence information incorporated in patents and make faster and more reliable business decisions.
“Patented biological sequence databases today are fragmented, duplicative, and time-consuming to search and analyze,” said Jon Brett-Harris, executive vice president, Life Sciences at Thomson Reuters. “We are delighted to be working with GenomeQuest to incorporate our renowned GENESEQ database with their IP discovery tools and GQ-Pat. This collaboration gives access to a comprehensive store of information through an intuitive interface designed with the biological patent sequence researcher in mind.”
Ron Ranauro, CEO of GenomeQuest, said, “Searching for unique information in this combined solution, scientists can benefit by identifying information not available in the public domain, linking genes and targets to disease and giving them access to an easy-to-use source of patent information that can quickly give them an indication of patent activity around their molecule of interest.”
About GenomeQuest
GenomeQuest, the leader in sequence data management (SDM) helps genomic researchers and their organizations make great discoveries far faster. Over 160 leading life science companies use GenomeQuest for mission-critical work, including 16 of the top 20 pharmaceuticals. Learn more at www.genomequest.com.
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto Stock Exchange (TSX: TRI) and New York Stock Exchange (NYSE: TRI). For more information, go to www.thomsonreuters.com.
Media Contact
Susan Besaw
Thomson Reuters
Tel: +1 215-823-1840
Email